Tonight on Nightly Business Report, Pfizer beats out its rivals to buy the maker of a blockbuster cancer drug for billion. Plus, the former CEO from the high-flying dot com days who is returning to the U.S. after being indicted a decade ago.
Tonight on Nightly Business Report, Pfizer beats out its rivals to buy the maker of a blockbuster cancer drug for billion. Plus, the former CEO from the high-flying dot com days who is returning to the U.S. after being indicted a decade ago.